Inhibitor Therapeutics, Inc. SEC filings INTI

Inhibitor Therapeutics, Inc. has 724 filings in SEC EDGAR's recent list, going back to Jul 21, 1997. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 18, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.

Inhibitor Therapeutics, Inc. SEC filings
Form Description Filed Period
UPLOAD Letter from the SEC Sep 15, 2025 —
CORRESP Letter to the SEC Jul 22, 2025 —
UPLOAD Letter from the SEC Jul 17, 2025 —
EFFECT Filing Apr 30, 2019 —
CT ORDER Filing Apr 1, 2019 —
EFFECT Filing Apr 17, 2018 —
CT ORDER Filing Jan 22, 2018 —
EFFECT Filing Apr 25, 2017 —
EFFECT Filing Jul 22, 2016 —
CORRESP Letter to the SEC Jul 21, 2016 —
CORRESP Letter to the SEC Jul 18, 2016 —
UPLOAD Letter from the SEC Jul 6, 2016 —
D Filing Apr 22, 2016 —
RW Request for withdrawal Mar 22, 2016 —
CT ORDER Filing Nov 13, 2015 —
CT ORDER Filing Nov 13, 2015 —
EFFECT Filing Aug 10, 2015 —
CORRESP Letter to the SEC Aug 6, 2015 —
CT ORDER Filing Oct 17, 2014 —
UPLOAD Letter from the SEC Sep 26, 2014 —
CT ORDER Filing Sep 8, 2014 —
NT 10-K Notification of late filing Mar 31, 2014 Dec 31, 2013
CT ORDER Filing Oct 10, 2013 —
NT 10-Q Notification of late filing May 15, 2013 Mar 31, 2013
NT 10-K Notification of late filing Apr 1, 2013 Dec 31, 2012
NT 10-Q Notification of late filing Nov 13, 2012 Sep 30, 2012
NT 10-Q Form 12b-25 Aug 14, 2012 Jun 30, 2012
NT 10-K Notification of late filing Mar 30, 2012 Dec 31, 2011
NT 10-Q Notification of late filing Aug 12, 2011 Jun 30, 2011
NT 10-Q Notification of late filing May 16, 2011 Mar 31, 2011
15-12B/A Form 15-12b/a Mar 22, 2011 —
15-12B Deregistration Mar 14, 2011 —
NO ACT Auto-generated paper document Jan 14, 2011 Jan 4, 2011
NO ACT Auto-generated paper document Dec 28, 2010 Nov 18, 2010
25-NSE Delisting notice Apr 9, 2010 —
UPLOAD Letter from the SEC Sep 15, 2009 —
PRER14A Preliminary revised notice and proxy Sep 14, 2009 —
UPLOAD Letter from the SEC Sep 10, 2009 —
PRER14A Filing Sep 1, 2009 —
UPLOAD Letter from the SEC May 26, 2009 —
UPLOAD Letter from the SEC Feb 27, 2009 —
CORRESP Letter to the SEC Feb 26, 2009 —
UPLOAD Letter from the SEC Feb 25, 2009 —
UPLOAD Letter from the SEC Jan 26, 2009 —
UPLOAD Letter from the SEC Jan 14, 2009 —
UPLOAD Letter from the SEC Jan 8, 2009 —
NT 10-Q Filing Nov 17, 2008 Sep 30, 2008
10QSB Form 10qsb Aug 14, 2008 Jun 30, 2008
10QSB Form 10-qsb May 20, 2008 Mar 31, 2008
NT 10-Q Notification of late filing May 15, 2008 Mar 31, 2008
EFFECT Filing Apr 30, 2008 —
10KSB/A Form 10-ksb/a Apr 30, 2008 Dec 31, 2007
CORRESP Letter to the SEC Apr 30, 2008 —
UPLOAD Letter from the SEC Apr 29, 2008 —
10KSB Form 10-ksb Apr 9, 2008 Dec 31, 2007
NT 10-K Notification of late filing Apr 1, 2008 Dec 31, 2007
CORRESP Letter to the SEC Feb 29, 2008 —
UPLOAD Letter from the SEC Feb 7, 2008 —
SB-2 Commonwealth biotechnologies, inc. Jan 30, 2008 —
REGDEX Auto-generated paper document Jan 15, 2008 —
10QSB Form 10-qsb Nov 14, 2007 Sep 30, 2007
10QSB Form 10-qsb Aug 22, 2007 Jun 30, 2007
NT 10-Q Notification of late filing Aug 15, 2007 Jun 30, 2007
10QSB Form 10-qsb May 15, 2007 Mar 31, 2007
10KSB Form 10-ksb Mar 30, 2007 Dec 31, 2006
DFAN14A Form dfan14a Jan 5, 2007 —
10QSB Form 10-qsb Nov 14, 2006 Sep 30, 2006
REGDEX Auto-generated paper document Sep 29, 2006 —
10QSB Form 10-qsb Aug 11, 2006 Jun 30, 2006
10QSB Form 10-qsb May 15, 2006 Mar 31, 2006
10KSB Form 10-ksb Mar 31, 2006 Dec 31, 2005
10QSB Form 10-qsb Nov 10, 2005 Sep 30, 2005
10QSB Form 10-qsb Aug 15, 2005 Jun 30, 2005
10QSB Form 10-qsb May 16, 2005 Mar 31, 2005
10KSB Form 10-ksb Mar 30, 2005 Dec 31, 2004
10QSB Form 10-qsb for period ended september 30, 2004 Nov 15, 2004 Sep 30, 2004
10QSB For the quarterly period ended june 30, 2004 Aug 16, 2004 Jun 30, 2004
REGDEX Auto-generated paper document Jun 3, 2004 —
10QSB For the quarter ended march 31,2004 May 17, 2004 Mar 31, 2004
10KSB Form 10-ksb Mar 30, 2004 Dec 31, 2003
10QSB Form 10-qsb Nov 14, 2003 Sep 30, 2003
10QSB Form 10qsb Aug 14, 2003 Jun 30, 2003
10QSB Quarterly report May 15, 2003 Mar 31, 2003
10KSB Form 10-ksb Mar 31, 2003 Dec 31, 2002
10QSB Form 10-qsb dated september 30, 2002 Nov 14, 2002 Sep 30, 2002
REGDEX Auto-generated paper document Sep 10, 2002 —
10QSB Form 10-qsb Aug 13, 2002 Jun 30, 2002
10QSB Form 10qsb May 14, 2002 Mar 31, 2002
10KSB/A Form 10ksb/a Apr 2, 2002 Dec 31, 2001
10KSB Form 10-ksb Apr 1, 2002 Dec 31, 2001
10QSB/A Form 10-qsb/a dated 09/30/2001 Nov 15, 2001 Sep 30, 2001
10QSB Form 10-qsb dated 09/30/2001 Nov 13, 2001 Sep 30, 2001
10QSB Form 10-qsb Aug 14, 2001 Jun 30, 2001
10QSB 10-qsb for the period ended 3/31/2001 May 15, 2001 Mar 31, 2001
10QSB Quarterly report Nov 14, 2000 Sep 30, 2000
DEFS14A Definitive special notice and proxy Oct 3, 2000 Oct 20, 2000
PRES14A Preliminary proxy statement Sep 15, 2000 Oct 20, 2000
10QSB Form 10-qsb Aug 14, 2000 Jun 30, 2000
10QSB/A Quarterly report for a small business Jun 5, 2000 Mar 31, 2000
10QSB/A Quarterly report for a small business May 31, 2000 Mar 31, 2000
10QSB Quarterly report for a small business May 12, 2000 Mar 21, 2000
10KSB Form 10-ksb Mar 30, 2000 Dec 31, 1999
10QSB Filing Nov 15, 1999 Sep 30, 1999
10QSB Commonwealth biotechnologies inc. 10qsb Aug 16, 1999 Jun 30, 1999
10QSB Commonwealth biotechnologies, inc. 10qsb May 17, 1999 Mar 31, 1999
10KSB Commonwealth--form 10-ksb Mar 31, 1999 Dec 31, 1998
DEFR14A Commonwealth biotechnologies, inc. defr14a Mar 24, 1999 —
10QSB Cbi, inc. 3rd quarter 10qsb Nov 13, 1998 Sep 30, 1998
10QSB Commonwealth biotechnologies, inc. 10qsb May 15, 1998 Mar 31, 1998
10KSB Commonwealth biotechnologies, inc. 10-ksb Mar 31, 1998 Dec 31, 1997
10QSB/A Commonwealth biotechnologies, inc. 10qsb/a Dec 11, 1997 Sep 30, 1997
10QSB Commonwealth biotechnologies, inc. 10qsb Dec 8, 1997 Sep 30, 1997
NTN 10Q Commonwealth biotechnologies, inc nt 10-q Dec 2, 1997 Sep 30, 1997
SB-2/A Commonwealth biotechnologies, inc. sb-2/a Oct 14, 1997 —
8-A12B Commonwealth biotechnologies 8-a 12(b) Oct 7, 1997 —
SB-2/A Commonwealth biotechnologies, inc. sb-2/a Oct 7, 1997 —
SB-2/A Commonwealth biotechnologies, inc. sb-2/a Sep 10, 1997 —
SB-2 Commonwealth biotechnologies, inc. sb-2 Jul 21, 1997 —

Showing 118 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
INTI (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Tampa, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1042418
Former names
HedgePath Pharmaceuticals, Inc. (until Aug 12, 2019); COMMONWEALTH BIOTECHNOLOGIES INC (until May 20, 2013)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.